TheFly.com
Start Free Trial
Open Search
keyboard_arrow_down
Type symbol to search
This symbol is non-existent:
List is empty.
Search
NTLA
Intellia Therapeutics
$
()
NTLA
Intellia Therapeutics announces first patient dosed in Phase 3 MAGNITUDE study
NTLA
3/18/2024 - 07:38am
Intellia Therapeutics just downgraded at Goldman Sachs, here's why
NTLA
2/23/2024 - 09:18am
Intellia Therapeutics price target lowered by $14 at Guggenheim, here's why
NTLA
2/23/2024 - 08:47am
Intellia Therapeutics price target raised by $1 at Canaccord, here's why
NTLA
2/23/2024 - 07:22am
Intellia Therapeutics reports Q4 EPS ($1.46), consensus ($1.45)
NTLA
2/22/2024 - 07:35am
Intellia Therapeutics price target lowered by $14 at Baird, here's why
NTLA
,
ALNY
2/16/2024 - 07:14am
Intellia Therapeutics, ReCode Therapeutics to develop genomic medicines for CF
NTLA
2/15/2024 - 07:43am
Intellia Therapeutics, ReCode Therapeutics announce collaboration
NTLA
2/15/2024 - 07:36am
Intellia Therapeutics initiated with neutral view at Wolfe Research, here's why
NTLA
2/14/2024 - 19:23pm
Intellia Therapeutics initiated with neutral view at Wolfe Research
NTLA
2/14/2024 - 16:16pm
Cathie Wood's ARK Investment bought 131K shares of Intellia Therapeutics today
NTLA
2/5/2024 - 20:04pm
Intellia Therapeutics announces publication of NTLA-2002 data in NEJM
NTLA
1/31/2024 - 17:02pm
Cantor Fitzgerald biotech analysts hold an analyst/industry conference call
MREO
,
ARWR
,
BEAM
…
1/30/2024 - 13:15pm
Cantor Fitzgerald biotech analysts hold an analyst/industry conference call
MREO
,
ARWR
,
BEAM
…
1/30/2024 - 10:55am
Intellia Therapeutics price target lowered by $13 at Stifel, here's why
NTLA
1/8/2024 - 09:55am
dynamic_feed
Breaking News
search
Search
menu
Menu